Form 4 for SPRY ARS Pharmaceuticals, Inc.
Accepted 2024-08-21 00:00:00 ET · period of report 2024-08-20 · accession 0001415889-24-021886 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-21 | 2024-08-20 | SPRY | Dorsey Brian | COO | M - OptEx | $0.64 | +50.0K | 56.0K | +830% | +$32.0K |
| D | 2024-08-21 | 2024-08-20 | SPRY | Dorsey Brian | COO | S - Sale+OE | $15.00 | -50.0K | 6,024 | -89% | -$750.0K |
| D | 2024-08-21 | 2024-08-20 | SPRY | Dorsey Brian | COO | M - OptEx | $0.00 | -50.0K | 61.8K | -45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-20 | M | A | 50,000 | $0.64 | 56,024 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-20 | S | D | 50,000 | $15.00 | 6,024 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-08-20 | M | D | 50,000 | $0.00 | 61,828 | D | $0.64 · — to 2028-11-28 | 50,000 Common Stock | (F2) Immediately exercisable. |